Angelo Tanna
Program Director · McGaw Medical Center of Northwestern University
Credentials: · · ·
History
- Present
Department of Ophthalmology · McGaw Medical Center of Northwestern University
Research
Review · Medical Clinics of North America · 2021 · 275 citations
Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension
Review · Ophthalmology · 2018 · First of 2 authors · Corresponding · 204 citations
Nature Communications · 2017 · 104 citations
- DB
6 papers
- RF
6 papers
5 papers · 5 as a resident
- HE
4 papers · 4 as a resident
4 papers · 1 as a resident
4 papers · 2 as a resident
3 papers · 3 as a fellow
- DS
3 papers · 3 as a resident
Clinical trials
- 2020–2022
Principal investigator · Terminated
Northwestern University
- 2011–2013
Glaucoma Eye Drop Instillation: Impact of Education
Principal investigator · Terminated
Northwestern University
- 2011–2015
Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
Study director · Completed · Phase 4
Aeon Astron Europe B.V.
- 2021–2027
Clarifying the Optimal Application of SLT Therapy Trial
Site PI · Recruiting · Phase 3
University of Pittsburgh